Pavaki Capital Management LLC

Position in OGN — Organon & Co.

CIK 2143027

Position in OGN

as of Mar 31, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,965,319

-$3,255,158 QoQ

Shares Held

328,100

-54.9% QoQ

Ownership

0.125%

of shares outstanding

% of Portfolio

1.43%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Pavaki Capital Management LLC holds $2,766,232 across 5 Drug Manufacturers - General names.

#	Ticker	Company	Shares	Value (USD)
1	SNY	Sanofi	20,000	$853,200
2	BIIB	Biogen Inc.	3,500	$756,210
3	MRK	Merck & Co., Inc.	5,000	$642,500
4	PFE	Pfizer Inc	12,400	$298,592
5	NVO	Novo Nordisk A S	4,500	$215,730

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,965,319	328,100	-54.9%	Shares	Sole	2026-08-07
2025-12-31	$5,220,477	728,100	—	Shares	Sole	2026-08-07
No filing history on record for this holder in this stock.